At present, the regulatory role of SH2B3 in stem cell proliferation and inflammation response remains unclear in patients with coronary artery disease, especially in post-myocardial infarction repair leading either to regeneration or inflammatory fibrosis of the myocardium [9,13]. Here, SH2B3 is linked to coronary artery disorder.